A daily coffee can help you live longer. That coffee frappe? Not so much.

A daily coffee can help you live longer. That coffee frappe? Not so much.

For years, science has known about the link between longer life and coffee consumption. But a new study, for the first time, weighs the effects of sweeteners. The findings suggest that the morning coffee routine is healthy if you don't overdo the sugar.

Read More

2021 was a Great Year for Longevity Research

2021 was a Great Year for Longevity Research

After years of being regarded as a red-headed stepchild of science, longevity is where the research and investment action is. A new report by Longevity Technology shows a great roundup of highlights from throughout the year, including top scientific breakthroughs, big investments, and research about consumer attitudes.

Read More

Remarkable 36% Lifespan Extension in Female Mice When Given Ovary Transplant

Remarkable 36% Lifespan Extension in Female Mice When Given Ovary Transplant

Our PubMed screening during February 2020 had several especially noteworthy papers to choose from to highlight in our blog. Ultimately however, we decided to focus on this report of a remarkable 36% extension of average female mouse lifespan when given an ovarian transplant in middle-age. These results suggest that, at least in females, ovarian function may affect healthspan and lifespan to a greater extent than is usually appreciated at the present time. 

Read More

Mark Your Calendars: Updated 2020 Longevity Conferences

Mark Your Calendars: Updated 2020 Longevity Conferences

One of the best way to meet others in our community and stay current  is to attend several conventions and events hosted by institutions focused on Longevity. The following is a list of events in chronological order that will add to your knowledge base. Special thanks to John D. Furber for compiling this comprehensive list!

Read More

Reconsidering Alzheimer's Disease

Reconsidering Alzheimer's Disease

In light of the underwhelming efficacy of human anti-Abeta clinical trials in the last several years, we are pleased to read the scientific community starting to reconsider the theory that amyloid beta (Abeta) is the primary causative factor in Alzheimer's disease. This paper is among several we've seen over the past year which criticizes the amyloid cascade hypothesis, and does a good job of balancing the supportive and contradictory evidence for the hypothesis.

Read More